A simple screening process may enhance monoclonal antibody-based drug development

(American Association for the Advancement of Science) By screening potential monoclonal antibody (mAb)-based drugs solely based on a measure of their colloidal stability, scientists may be able to weed out mAbs that do not respond efficiently in solution early in the